Live feed
Filing
SC 13D/A
SC 13D/A0000950142-21-003501·Javitt Jonathan C
Schedule 13D ownership disclosure
NRX PHARMACEUTICALS INC
Security class unavailable · CUSIP: 629444100
Event date: 2021-07-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 48.1900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950142-21-003501
- Form type
- SC 13D/A
- Filer
- Javitt Jonathan C
- CIK
- CIK 1303782
- Filed
- Nov 02, 2021
- Reporting period
- Jul 16, 2021
- Description
- Schedule 13D beneficial ownership